Automatic brain stereotaxic device market is anticipated to grow at a CAGR of 5.9% during the forecast period. Advances in neuroscience research, a rising number of neurological illnesses, and the growing acceptance of minimally invasive surgical procedures are driving the need for brain stereotaxic devices. Furthermore, technical advances in imaging modalities and the creation of more precise and accurate stereotaxic systems have aided in the expansion of this industry.

Because of continuous R&D in the fields of neurosurgery and neuroscience, the market for autonomous brain stereotaxic devices is expected to grow significantly in near future. As our understanding of the brain improves and new treatment options emerge, the need for precision targeting and administration of medicines is expected to rise, propelling the brain stereotaxic device market forward. 

Significant investments in healthcare infrastructure development are being made in emerging nations. This includes the creation of superior medical facilities as well as the use of cutting-edge medical technologies. As healthcare infrastructure improves, so will the accessibility and acceptance of automated brain stereotaxic devices, boosting market expansion.

The increasing prevalence of neurological disorders, advancements in neurosurgical procedures and medical imaging, R&D programs, demand for personalised medicine, growing healthcare infrastructure, and the rising geriatric population are driving the automatic brain stereotaxic device market.

Segmental Outlook

The global automatic brain stereotaxic device market is segmented based on type and application. Based on type, the market is segmented into rotary type, orbital type, and others. Based on application, the market is segmented into for rats, for dogs, and others.

North America Region held Considerable Share in the Global Automatic Brain Stereotaxic Device Market 

North America is a large market for automated brain stereotaxic devices owing to its well-established healthcare infrastructure and strong presence of important market participants. Advanced medical imaging technology, a high frequency of neurological illnesses, and a significant concentration on R&D benefit the region. The existence of famous medical institutions and technical breakthroughs, the US leads the market in North America.

Recent Developments

• In January 2023, GE HealthCare stated that it has agreed to buy IMACTIS, a pioneer in the rapidly developing field of Computed Tomography (CT) interventional guiding across a wide variety of service areas. 

• In August 2022, Elekta announced that its Elekta Esprit, a new Leksell Gamma Knife radiosurgery platform, had received CE certification. This regulatory clearance is the first step towards allowing people with brain illnesses to be treated with this cutting-edge gadget in Europe and other countries where the CE mark is recognised, and eventually the rest of the globe. 

Market Coverage

? The market number available for – 2022-2030

? Base year- 2022

? Forecast period- 2023-2030

? Competitive Landscape- Shenzhen Reward Life Technology Co., Ltd., Anhui Zhenghua Biological Instrument Equipment Co., Ltd., Shanghai Yuyan Scientific Instrument Co., Ltd., Beijing Youcheng Jiaye Biotechnology Co., Ltd., among others

Global Automatic Brain Stereotaxic Device Market Report Segment

By Type

• Rotary Type
• Orbital Type
• Others

By Application

• For Rat
• For Dogs
• Others

Global Automatic Brain Stereotaxic Device Market Report Segment by Region

North America

? United States

? Canada

Europe

? UK

? Germany

? Italy

? Spain

? France

? Rest of Europe 

Asia-Pacific

? China

? India

? Japan

? South Korea

? Rest of Asia-Pacific 

Rest of the World

? Latin America 

? Middle East & Africa